Novartis to Acquire Synnovation Therapeutics’ Pan-Mutant Selective PI3Kα Inhibitor Program
Synnovation will receive total cash consideration of up to $3 billion, consisting of $2 billion in upfront cash…
UBS Remains Neutral on indie Semiconductor (INDI)
indie Semiconductor, Inc. (NASDAQ:INDI) is one of the top must-buy semiconductor stocks to invest in now. UBS lifted the…